Faber-Elman A, Solomon A, Abraham J A, Marikovsky M, Schwartz M
Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.
J Clin Invest. 1996 Jan 1;97(1):162-71. doi: 10.1172/JCI118385.
The poor ability of mammalian central nervous system (CNS) axons to regenerate has been attributed, in part, to astrocyte behavior after axonal injury. This behavior is manifested by the limited ability of astrocytes to migrate and thus repopulate the injury site. Here, the migratory behavior of astrocytes in response to injury of CNS axons in vivo was simulated in vitro using a scratch-wounded astrocytic monolayer and soluble substances derived from injured rat optic nerves. The soluble substances, applied to the scratch-wounded astrocytes, blocked their migration whereas some known wound-associated factors such as transforming growth factor-beta 1 (TGF-beta 1), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and heparin-binding epidermal growth factor in combination with insulin-like growth factor-1 (HB-EGF + IGF-1) stimulated intensive migration with consequent closure of the wound. Migration was not dominated by proliferating cells. Both bFGF and HB-EGF + IGF-1, but not TGF-beta 1, could overcome the blocking effect of the optic nerve-derived substances on astrocyte migration. The induced migration appeared to involve proteoglycans. It is suggestive that appropriate choice of growth factors at the appropriate postinjury period may compensate for the endogenous deficiency in glial supportive factors and/or presence of glial inhibitory factors in the CNS.
哺乳动物中枢神经系统(CNS)轴突再生能力较差,部分原因可归咎于轴突损伤后星形胶质细胞的行为。这种行为表现为星形胶质细胞迁移能力有限,因此无法重新填充损伤部位。在此,利用划痕损伤的星形胶质细胞单层以及源自受伤大鼠视神经的可溶性物质,在体外模拟了体内星形胶质细胞对CNS轴突损伤的迁移行为。将可溶性物质施加于划痕损伤的星形胶质细胞后,会阻断其迁移,而一些已知的与伤口相关的因子,如转化生长因子-β1(TGF-β1)、碱性成纤维细胞生长因子(bFGF)、表皮生长因子(EGF)——转化生长因子-α(TGF-α)以及肝素结合表皮生长因子与胰岛素样生长因子-1(HB-EGF + IGF-1)联合使用时,会刺激强烈的迁移,从而使伤口闭合。迁移并非由增殖细胞主导。bFGF和HB-EGF + IGF-1均可克服视神经来源物质对星形胶质细胞迁移的阻断作用,但TGF-β1则不能。诱导的迁移似乎涉及蛋白聚糖。这表明在损伤后的适当时期适当选择生长因子,可能会弥补中枢神经系统中胶质支持因子的内源性不足和/或胶质抑制因子的存在。